Trichomonal vulvovaginitis
ICD-10 A59.01 is a billable code used to indicate a diagnosis of trichomonal vulvovaginitis.
Trichomonal vulvovaginitis is a sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis. It primarily affects the urogenital tract, leading to inflammation of the vulva and vagina. Patients may present with symptoms such as itching, burning, and a frothy, malodorous discharge. The infection is often asymptomatic, particularly in men, which can contribute to its spread. Diagnosis is typically made through laboratory testing, including wet mount microscopy or nucleic acid amplification tests (NAATs). Treatment usually involves the administration of metronidazole or tinidazole, with both partners needing treatment to prevent reinfection. Contact tracing is crucial in managing trichomonal infections, as it helps identify and treat sexual partners, thereby reducing transmission rates. Education on safe sexual practices is also an essential component of management.
Detailed patient history, including sexual history and symptoms.
Patients presenting with vaginal discharge, itching, or burning.
Ensure documentation includes partner treatment and follow-up plans.
Comprehensive records of laboratory tests and treatment regimens.
Management of recurrent trichomoniasis and co-infections.
Focus on patient education regarding prevention and safe practices.
Used when laboratory confirmation of trichomoniasis is needed.
Document the reason for testing and patient consent.
Ensure proper coding for the test based on the specialty performing it.
Common symptoms include itching, burning, and a frothy, foul-smelling discharge. However, many individuals may be asymptomatic.
Treatment typically involves metronidazole or tinidazole, and it is important to treat both partners to prevent reinfection.
Contact tracing helps identify and treat sexual partners, reducing the risk of reinfection and further transmission of the infection.
